Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merkel cell carcinoma
Merkel cell carcinoma
Natera touts positive results for Merkel cell carcinoma surveillance test
Clinical Trials Arena
Mon, 07/29/24 - 10:45 pm
Natera
diagnostics
Medtech
Merkel cell carcinoma
In a surprise approval, FDA green-lights Incyte's PD-1 inhibitor to treat rare cancer type
Fierce Pharma
Wed, 03/22/23 - 09:27 pm
Incyte
Zynyz
FDA
Merkel cell carcinoma
Merck's Keytruda puts heat on Pfizer, Merck KGaA's Bavencio with new Merkel cell OK
Fierce Pharma
Thu, 12/20/18 - 10:12 am
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
Merck's Keytruda threatens Pfizer, Merck KGaA's Bavencio with Merkel cell 'priority' tag
Fierce Pharma
Tue, 09/4/18 - 11:05 am
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
FDA
NeoImmuneTech and Roche Collaborate in Clinical Trial of HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
CP Wire
Wed, 05/2/18 - 09:58 am
NeoImmune Tech
Genexine
Roche
R&D
melanoma
Merkel cell carcinoma
cutaneous squamous cell carcinoma
How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment
Motley Fool
Thu, 03/15/18 - 09:55 am
cancer
oncology
Pfizer
Ibrance
breast cancer
Xtandi
prostate cancer
Bavencio
bladder cancer
Merkel cell carcinoma
lorlatinib
metastatic non-small cell lung cancer
talazoparib
metastatic breast cancer
Pfizer, Merck KGaA nab NICE's favor for Bavencio in Merkel cell carcinoma
Fierce Pharma
Sat, 03/3/18 - 10:42 am
Pfizer
Merck KGaA
NICE
Bavencio
Merkel cell carcinoma
Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod
Yahoo/Reuters
Thu, 09/21/17 - 08:38 am
Bavencio
Europe
Merck KGaA
Pfizer
Merkel cell carcinoma
German Merck, Pfizer get FDA priority review for cancer drug
Yahoo/Reuters
Tue, 11/29/16 - 09:55 am
Merck KGaA
Pfizer
FDA
Merkel cell carcinoma
skin cancer
avelumab
Can Pfizer Make Headway In A Rare Skin Tumor?
Seeking Alpha
Tue, 07/19/16 - 09:42 am
Pfizer
avelumab
Merkel cell carcinoma
Merck KGaA/Pfizer analysis of PD-L1 drug for rare skin cancer shows encouraging interim results
BioPharma Dive
Fri, 05/20/16 - 10:28 am
Merck KGaA
Pfizer
PD-L1
Merkel cell carcinoma